WASHINGTON (dpa-AFX) - Alexion Pharmaceuticals Inc. (ALXN) announced a profit for first quarter that fell compared to the same period last year.
The company said its bottom line dropped to $253.78 million, or $1.11 per share. This was down from $261.98 million, or $1.28 per share, in last year's first quarter.
Analysts had expected the company to earn $1.14 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company said revenue for the quarter rose 16.8% to $701.04 million. This was up from $600.33 million last year.
Alexion Pharmaceuticals Inc. earnings at a glance:
-Earnings (Q1): $253.78 Mln. vs. $261.98 Mln. last year. -Earnings Decline (Y-o-Y): -3.1% -EPS (Q1): $1.11 vs. $1.28 last year. -EPS Decline (Y-o-Y): -13.3% -Analysts Estimate: $1.14 -Revenue (Q1): $701.04 Mln vs. $600.33 Mln last year. -Revenue Change (Y-o-Y): 16.8%
-Guidance: Full year EPS guidance: $5.00 - $5.20 Full year revenue guidance: $3.050 - $3.100 Bln
Copyright RTT News/dpa-AFX